EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome
dc.contributor.author | Drosos, George C. | |
dc.contributor.author | Vedder, Daisy | |
dc.contributor.author | Houben, Eline | |
dc.contributor.author | Boekel, Laura | |
dc.contributor.author | Atzeni, Fabiola | |
dc.contributor.author | Badreh, Sara | |
dc.contributor.author | Boumpas, Dimitrios T. | |
dc.contributor.author | Brodin, Nina | |
dc.contributor.author | Bruce, Ian N. | |
dc.contributor.author | González-Gay, Miguel Ángel | |
dc.contributor.author | Jacobsen, Søren | |
dc.contributor.author | Kerekes, György | |
dc.contributor.author | Marchiori, Francesca | |
dc.contributor.author | Mukhtyar, Chetan | |
dc.contributor.author | Ramos-Casals, Manuel | |
dc.contributor.author | Sattar, Naveed | |
dc.contributor.author | Schreiber, Karen | |
dc.contributor.author | Sciascia, Savino | |
dc.contributor.author | Svenungsson, Elisabet | |
dc.contributor.author | Szekanecz, Zoltan | |
dc.contributor.author | Tausche, Anne-Kathrin | |
dc.contributor.author | Tyndall, Alan | |
dc.contributor.author | van Halm, Vokko | |
dc.contributor.author | Voskuyl, Alexandre | |
dc.contributor.author | Macfarlane, Gary | |
dc.contributor.author | Ward, Michael M. | |
dc.contributor.author | Nurmohamed, Michael T. | |
dc.contributor.author | Tektonidou, Maria G. | |
dc.date.accessioned | 2022-05-05T23:05:19Z | |
dc.date.available | 2022-05-05T23:05:19Z | |
dc.date.issued | 2022-05-16 | |
dc.identifier.citation | Drosos , G C , Vedder , D , Houben , E , Boekel , L , Atzeni , F , Badreh , S , Boumpas , D T , Brodin , N , Bruce , I N , González-Gay , M Á , Jacobsen , S , Kerekes , G , Marchiori , F , Mukhtyar , C , Ramos-Casals , M , Sattar , N , Schreiber , K , Sciascia , S , Svenungsson , E , Szekanecz , Z , Tausche , A-K , Tyndall , A , van Halm , V , Voskuyl , A , Macfarlane , G , Ward , M M , Nurmohamed , M T & Tektonidou , M G 2022 , ' EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome ' , Annals of the Rheumatic Diseases , vol. 81 , pp. 768-779 . https://doi.org/10.1136/annrheumdis-2021-221733 | en |
dc.identifier.issn | 0003-4967 | |
dc.identifier.other | PURE: 211247801 | |
dc.identifier.other | PURE UUID: 165fd5b6-5140-4a58-b835-7d7918c58743 | |
dc.identifier.other | ORCID: /0000-0003-2322-3314/work/114480469 | |
dc.identifier.other | Scopus: 85125531096 | |
dc.identifier.uri | https://hdl.handle.net/2164/18533 | |
dc.description | Acknowledgements: The committee wishes to acknowledge the support of the EULAR Standing Committee on Clinical Affairs and the EULAR Secretariat. Funding: This study was funded by European Alliance of Associations for Rheumatology, EULAR. Project number: CLI112 | en |
dc.format.extent | 12 | |
dc.language.iso | eng | |
dc.relation.ispartof | Annals of the Rheumatic Diseases | en |
dc.rights | This is the accepted version of [full cite]. Version of record can be found at [DOI] | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Recommendations | en |
dc.subject | cardiovascular disease | en |
dc.subject | rheumatic and musculoskeletal disease | en |
dc.subject | traditional cardiovascular risk factors | en |
dc.subject | disease-related risk factors | en |
dc.subject | R Medicine | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | R | en |
dc.title | EULAR recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases, including Systemic Lupus Erythematosus and Antiphospholipid Syndrome | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Vice Principals | en |
dc.contributor.institution | University of Aberdeen.Epidemiology Group | en |
dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH) | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1136/annrheumdis-2021-221733 | |
dc.date.embargoedUntil | 2022-05-06 | |
dc.identifier.vol | 81 | en |